The aim of this study was to investigate whether PRP contains an angiogenesis inhibitor, thrombospondin-1 (TSP-1), and whether this factor negatively affects human cells associated with oral healing in vitro.
The objective of this study is to evaluate the efficacy, safety and cost-effectiveness of intra-operative cell salvage (CS) in high-bleeding-risk cardiac surgery with cardiopulmonary bypass (CPB).
